Study may provide insight into how R-LA promotes death of hepatoma cells

A new study that measured metabolite levels over time in starved rat liver cancer cells showed that treatment with a form of alpha-lipoic acid (LA) inhibited glucose uptake and glycolysis, and led to decreased cellular glucose production from non-carbohydrate sources, which may help explain how the naturally occurring R enantiomeric form of LA (R-LA) promotes the death of hepatoma cells. Researchers supported their findings with measurements of amino acid metabolism and lactic acid production in R-LA and untreated hepatoma cells, as reported in Journal of Medicinal Food, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Medicinal Food website until May 11, 2017.

LA is a powerful antioxidant and R-LA is an essential cofactor in cellular energy metabolism. Naoko Ikuta, Seiichi Matsugo, and coauthors from Graduate School of Medicine, Kobe University, Kanazawa University, and CycloChem Bio Co. (Kobe), Japan, and University of Kiel, Germany, demonstrated that concentrations of the amino acids glycine, threonine, and serine, were significantly lower in R-LA treated rat hepatoma cells compared to in untreated cells or cells treated with the D-enantiomeric form of LA (D-LA). This indicates down-regulation of the Thr-Gly-Ser pathways and associated inhibition of gluconeogenesis from protein sources, as described in the article entitled "Time Course Effect of R-Alpha-Lipoic Acid on Cellular Metabolomics in Cultured Hepatoma Cells."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO